Psyence Biomedical (PBM) Competitors $1.72 -0.07 (-3.91%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PBM vs. CNSP, GLTO, KZIA, GRI, ADIL, ALZN, TRIB, GNPX, EVOK, and AEZSShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include CNS Pharmaceuticals (CNSP), Galecto (GLTO), Kazia Therapeutics (KZIA), GRI Bio (GRI), Adial Pharmaceuticals (ADIL), Alzamend Neuro (ALZN), Trinity Biotech (TRIB), Genprex (GNPX), Evoke Pharma (EVOK), and Aeterna Zentaris (AEZS). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. CNS Pharmaceuticals Galecto Kazia Therapeutics GRI Bio Adial Pharmaceuticals Alzamend Neuro Trinity Biotech Genprex Evoke Pharma Aeterna Zentaris CNS Pharmaceuticals (NASDAQ:CNSP) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations. Does the MarketBeat Community believe in CNSP or PBM? CNS Pharmaceuticals received 47 more outperform votes than Psyence Biomedical when rated by MarketBeat users. CompanyUnderperformOutperformCNS PharmaceuticalsOutperform Votes4771.21% Underperform Votes1928.79% Psyence BiomedicalN/AN/A Does the media refer more to CNSP or PBM? In the previous week, Psyence Biomedical had 1 more articles in the media than CNS Pharmaceuticals. MarketBeat recorded 1 mentions for Psyence Biomedical and 0 mentions for CNS Pharmaceuticals. CNS Pharmaceuticals' average media sentiment score of 0.00 equaled Psyence Biomedical'saverage media sentiment score. Company Overall Sentiment CNS Pharmaceuticals Neutral Psyence Biomedical Neutral Do analysts prefer CNSP or PBM? CNS Pharmaceuticals currently has a consensus target price of $0.50, suggesting a potential upside of 373.48%. Given CNS Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe CNS Pharmaceuticals is more favorable than Psyence Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CNS Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Psyence Biomedical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders hold more shares of CNSP or PBM? 14.0% of CNS Pharmaceuticals shares are owned by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are owned by institutional investors. 0.1% of CNS Pharmaceuticals shares are owned by insiders. Comparatively, 3.6% of Psyence Biomedical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, CNSP or PBM? CNS Pharmaceuticals has a beta of 2.52, meaning that its share price is 152% more volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of -0.45, meaning that its share price is 145% less volatile than the S&P 500. Is CNSP or PBM more profitable? Company Net Margins Return on Equity Return on Assets CNS PharmaceuticalsN/A N/A -515.32% Psyence Biomedical N/A N/A N/A Which has preferable valuation and earnings, CNSP or PBM? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCNS PharmaceuticalsN/AN/A-$18.85M-$74.970.00Psyence BiomedicalN/AN/A-$51.16MN/AN/A SummaryCNS Pharmaceuticals beats Psyence Biomedical on 6 of the 10 factors compared between the two stocks. Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBM vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.45M$6.57B$5.39B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A10.0188.8317.53Price / SalesN/A315.791,280.48134.21Price / CashN/A22.6336.6032.90Price / Book-0.035.084.964.69Net Income-$51.16M$154.90M$117.89M$224.57M7 Day Performance4.88%1.33%1.67%1.69%1 Month Performance-45.91%1.52%3.62%5.34%1 Year PerformanceN/A4.60%26.15%21.47% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMPsyence BiomedicalN/A$1.72-3.9%N/AN/A$1.45MN/A0.00N/APositive NewsGap DownCNSPCNS Pharmaceuticals1.9562 of 5 stars$0.12-0.7%$0.50+327.4%-99.7%$6.73MN/A0.005News CoveragePositive NewsGLTOGalecto3.3067 of 5 stars$5.09-0.8%$10.00+96.5%-65.0%$6.70MN/A-0.2740Positive NewsKZIAKazia Therapeutics3.1871 of 5 stars$1.51-4.4%$20.00+1,224.5%-58.9%$6.58M$2.31M0.0012Gap UpGRIGRI Bio2.7518 of 5 stars$0.73-4.3%$11.50+1,475.3%-97.2%$6.52MN/A-0.781ADILAdial Pharmaceuticals3.1295 of 5 stars$1.01-1.0%$8.00+692.1%-23.7%$6.47MN/A0.0020Positive NewsGap DownALZNAlzamend Neuro2.3283 of 5 stars$1.15+1.8%$32.00+2,682.6%-86.6%$6.25MN/A0.004Positive NewsTRIBTrinity Biotech1.507 of 5 stars$0.82-2.0%N/A-63.0%$6.25M$59.13M-0.36480Positive NewsGNPXGenprex4.24 of 5 stars$0.73-6.4%$10.00+1,269.7%-91.7%$6.21MN/A0.0020Positive NewsEVOKEvoke Pharma0.812 of 5 stars$4.17-0.7%N/A-51.7%$6.20M$8.62M-0.384Positive NewsAEZSAeterna ZentarisN/A$3.40+5.7%N/A-62.5%$6.10M$2.37M-0.2320Analyst Forecast Related Companies and Tools Related Companies CNS Pharmaceuticals Alternatives Galecto Alternatives Kazia Therapeutics Alternatives GRI Bio Alternatives Adial Pharmaceuticals Alternatives Alzamend Neuro Alternatives Trinity Biotech Alternatives Genprex Alternatives Evoke Pharma Alternatives Aeterna Zentaris Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PBM) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBM Stock Alerts